» Articles » PMID: 39090411

The Burden of Diabetes-associated Multiple Long-term Conditions on Years of Life Spent and Lost

Abstract

Diabetes mellitus is a central driver of multiple long-term conditions (MLTCs), but population-based studies have not clearly characterized the burden across the life course. We estimated the age of onset, years of life spent and loss associated with diabetes-related MLTCs among 46 million English adults. We found that morbidity patterns extend beyond classic diabetes complications and accelerate the onset of severe MLTCs by 20 years earlier in life in women and 15 years earlier in men. By the age of 50 years, one-third of those with diabetes have at least three conditions, spend >20 years with them and die 11 years earlier than the general population. Each additional condition at the age of 50 years is associated with four fewer years of life. Hypertension, depression, cancer and coronary heart disease contribute heavily to MLTCs in older age and create the greatest community-level burden on years spent (813 to 3,908 years per 1,000 individuals) and lost (900 to 1,417 years per 1,000 individuals). However, in younger adulthood, depression, severe mental illness, learning disabilities, alcohol dependence and asthma have larger roles, and when they occur, all except alcohol dependence were associated with long periods of life spent (11-14 years) and all except asthma associated with many years of life lost (11-15 years). These findings provide a baseline for population monitoring and underscore the need to prioritize effective prevention and management approaches.

Citing Articles

Clinical metabolomics in type 2 diabetes mellitus: from pathogenesis to biomarkers.

Liu C, Chen H, Ma Y, Zhang L, Chen L, Huang J Front Endocrinol (Lausanne). 2025; 16:1501305.

PMID: 40070584 PMC: 11893406. DOI: 10.3389/fendo.2025.1501305.


Multiple long-term conditions as the next transition in the global diabetes epidemic.

Gregg E, Holman N, Sophiea M, Misra S, Pearson-Stuttard J, Valabhji J Commun Med (Lond). 2025; 5(1):42.

PMID: 39953177 PMC: 11828996. DOI: 10.1038/s43856-025-00742-9.

References
1.
Gerstein H, Werstuck G . Dysglycaemia, vasculopenia, and the chronic consequences of diabetes. Lancet Diabetes Endocrinol. 2014; 1(1):71-8. DOI: 10.1016/S2213-8587(13)70025-1. View

2.
Nathan D . Long-term complications of diabetes mellitus. N Engl J Med. 1993; 328(23):1676-85. DOI: 10.1056/NEJM199306103282306. View

3.
Gregg E, Li Y, Wang J, Burrows N, Ali M, Rolka D . Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014; 370(16):1514-23. DOI: 10.1056/NEJMoa1310799. View

4.
Harding J, Pavkov M, Magliano D, Shaw J, Gregg E . Global trends in diabetes complications: a review of current evidence. Diabetologia. 2018; 62(1):3-16. DOI: 10.1007/s00125-018-4711-2. View

5.
Pearson-Stuttard J, Cheng Y, Bennett J, Vamos E, Zhou B, Valabhji J . Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records. Lancet Diabetes Endocrinol. 2021; 10(1):46-57. PMC: 8672063. DOI: 10.1016/S2213-8587(21)00288-6. View